Histiocytic neoplasms are rare myeloid diseases characterized by MAPK pathway-activating genetic alterations.
We investigated their hematopoietic origin, with a focus on non-Langerhans cell histiocytoses.
Using droplet digital polymerase chain reaction assays specific for
